All In Biotech

Free tool

FAERS Monitor: Xromi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216593 or its brand name (Xromi, Hydroxyurea). Reports on generic versions are filed under their own applications.

Reports

14,936

Serious

10,721

72% of reports

Hospitalization

5,227

Death reported

2,099

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,805
  • sickle cell anaemia with crisis1,246
  • fatigue1,160
  • diarrhoea1,111
  • nausea1,007
  • headache834
  • death786
  • product dose omission issue771
  • drug ineffective745
  • haemoglobin decreased682
  • anaemia676
  • pain651
  • pyrexia596
  • dyspnoea586
  • asthenia561

Reports by year received

View as table
YearReports
200491
200599
2006141
2007140
2008141
2009151
2010187
2011251
2012340
2013219
2014379
2015465
2016718
2017873
20181,087
2019958
20201,256
20211,456
20221,589
20231,439
20241,143
20251,058
2026755

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,223 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sickle cell anaemia with crisisSignal1,246120.8114.3136,338
haemoglobin decreasedSignal6829.48.75,108
anaemiaSignal6765.04.62,175
product dose omission issueSignal7713.73.51,533
off label useSignal1,8052.92.82,349
pyrexiaSignal5962.42.2507
diarrhoeaSignal1,1112.42.3958
astheniaSignal5612.11.9329
fatigueSignal1,1602.12.0692
headache8341.91.8349
nausea1,0071.81.7365
pain6511.51.4109
dyspnoea5861.51.386
death7861.31.251
drug ineffective7450.80.741

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.